Centene Corporation Common Stock (NY:CNC)

62.99 +2.00 (+3.28%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Centene Corporation Common Stock

< Previous 1 2

...

29 30 31 32 33 34 35 36 Next >

What Centene’s Next Era in Managed Care Looks Like ↗

April 13, 2022

New Centene CEO Sarah London faces pressure from activists to increase profits, and from government to deliver more care.

Via InvestorPlace

Biden To Propose Change To Obamacare To Extend Subsidies For Families: WSJ ↗

April 05, 2022

Via Benzinga

House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month ↗

April 01, 2022

The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare.

Via Benzinga

7 Healthcare Stocks to Buy for the Long Term ↗

March 21, 2022

When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks.

Via InvestorPlace

Recap: Centene Q4 Earnings ↗

February 08, 2022

Centene (NYSE:CNC) reported its Q4 earnings results on Tuesday, February 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Analyst Ratings For Centene ↗

January 07, 2022

Over the past 3 months, 9 analysts have published their opinion on Centene (NYSE:C...

Via Benzinga

Centene Corporation (CNC) Climbs to Annual-High Share Price

December 23, 2021

Via Investor Brand Network

Stock Market Rally Stalls As Inflation, Treasury Yields Soar: Weekly Review ↗

February 11, 2022

The stock market rally remains stuck in a recent range as the major indexes slashed weekly gains on hot inflation. Treasury yields surged.

Via Investor's Business Daily

Analyst Ratings For Centene ↗

February 09, 2022

Over the past 3 months, 9 analysts have published their opinion on Centene (NYSE:CNC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...

Via Benzinga

CVS Health Earnings Beat But Guidance Is Tepid; CVS Stock Slips ↗

February 09, 2022

CVS earnings topped estimates, though guidance implies an EPS dip in 2022.

Via Investor's Business Daily

Centene Shares Jump On Better Than Expected Q4 Earnings, Reaffirms FY22 Guidance ↗

February 08, 2022

Centene Corporation (NYSE: CNC) has reported Q4 adjusted EPS of $1.01,

Via Benzinga

Watch for Continued Gains in Shares of Centene Corporation (CNC)

December 15, 2021

Via Investor Brand Network

Expert Ratings For Centene ↗

December 13, 2021

Analysts have provided the following ratings for Centene (NYSE:CNC) within the...

Via Benzinga

A Peek Into The Markets: US Stock Futures Mostly Higher Ahead Of Earnings Reports ↗

February 08, 2022

Pre-open movers

Via Benzinga

5 Stocks To Watch For February 8, 2022 ↗

February 08, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects Pfizer Inc. (NYSE: PFE) to report quarterly earnings at $0.87 per share on revenue of $24.20 billion before the opening...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 31, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Teladoc Stock Is Due for a Major Upside Reversal ↗

January 26, 2022

Teladoc is worth at least $110 a share assuming its revenue grows at historical rates for the next few years.

Via InvestorPlace

5 Stocks Insiders Are Selling: Accenture, Centene And More ↗

January 25, 2022

French CAC 40 Index gained around 1% this morning, partially recovering from previous session’s 4% plunge, as investors await the policy decision from the Federal Reserve...

Via Benzinga

Earnings Scheduled For February 8, 2022 ↗

February 08, 2022

Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.

Via Benzinga

14 Stocks in the Healthcare Sector ↗

January 21, 2022

Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%.

Via Talk Markets

Clover Health Stock Investors Will Need to Buy Into Tech Chief’s Vision ↗

January 18, 2022

CTO Andrew Toy's innovations like Clover Assistant, seen by some as savior of CLOV stock, are already being adopted by larger Medicare Advantage players.

Via InvestorPlace

5 S&P 500 Stocks Set To Report Triple-Digits Earnings Growth ↗

January 13, 2022

Given the robust projections, most S&P 500 stocks are likely to post triple-digit earnings growth. Some of these are CF Industries, Exxon Mobil, Tesla, Centene Corporation, and Southwest Airlines.

Via Talk Markets

Bulls Should Begin 2022 With A Win ↗

January 03, 2022

The first trading day of the new year is seasonally very strong by a number of studies and that is reinforced by the late day weakness to end 2021.

Via Talk Markets

Centene Corporation Climbs to Annual-High Share Price ↗

December 23, 2021

Shares of Centene Corporation (NYSE: CNC) traded at a new 12-month high today of $85.02. So far today approximately 439,000 shares have been exchanged, as compared to an average...

Via Benzinga

Watch for Continued Gains in Shares of Centene Corporation ↗

December 15, 2021

Shares of Centene Corporation (NYSE: CNC) traded today at $83.08, eclipsing its 12-month high. So far today, approximately 1.7 million shares have been exchanged, as compared to...

Via Benzinga

4 Stocks Insiders Are Selling ↗

December 15, 2021

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...

Via Benzinga

CNBC's Final Call: Centene, Meta Platforms, And Consumer Staples ↗

December 13, 2021

On CNBC's "Options Action: The Final Call," Carter...

Via Benzinga

Amid More Evidence of Tough Competition, Teladoc Stock Remains a Sell ↗

December 01, 2021

Teladoc's slowing growth and increased spending indicates that its competition is increasingly tough, making TDOC stock a sell.

Via InvestorPlace

Teledoc Stock Will Break Out with New Product Features ↗

November 19, 2021

Teledoc’s product suite myStrength Complete and Primary 360 will enhance growth in the coming quarters and into 2023. With Teledoc's integration with Livongo's product features, the company is bound to...

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021 ↗

December 14, 2021

Upgrades According to Wells Fargo, the prior rating for Douglas Emmett Inc (NYSE:

Via Benzinga

< Previous 1 2

...

29 30 31 32 33 34 35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.